BioBuzz

These are just a few of the incredible faces we're celebrating in our 𝟮𝟬𝟮𝟰 𝗕𝗶𝗼𝗕𝘂𝘇𝘇 𝗔𝘄𝗮𝗿𝗱𝘀 (https://lnkd.in/enkwA2Gd). 🏆 Nominated by 𝙔𝙊𝙐, the 30 finalists across 6 categories in both the BioHealth Capital Region and Greater Philadelphia, represent a diverse pool of people, programs, and organizations driving innovation and making impact across the industry. Help us recognize and continue to celebrate them; 🎉 𝗩𝗢𝗧𝗘 today, and every day, between now and December 13. ➡️ https://lnkd.in/er8piHHE Better yet, help us share their stories and points of impact over the coming weeks thanks to our incredible partners US Pharmacopeia (USP), Avantor, MilliporeSigma, Blackbird Laboratories, Integral Molecular, Life Science Wealth, ScienceWerx, Inc, and Life Science Cares Philadelphia. #maryland #virginia #philadelphia #leadership #innovation #lifesciences

💲 How important can efficient waste management be? VERY! 💲 Tune in to our latest interview with Matt Georgov, Founder & CEO of Choice MedWaste, to find out how! A big thank you to the entire CIC (Cambridge Innovation Center) Philadelphia, uCity Square, and University City Science Center teams for organizing such an amazing event. Also, a special shoutout to Persephoni BioPartners for sponsoring the media room! Chris Frew Cat Thoreson Bryan Kennedy Annabel Baldy Owen Buzy

⭐ Shaping our workforce of the future! ⭐ Check out our latest interview with Maya Heiland at the CIC (Cambridge Innovation Center) Philadelphia vendor showcase! A big thank you to the entire CIC - Philadelphia, uCity Square, and University City Science Center teams for organizing such an amazing event. Also, a special shoutout to Persephoni BioPartners for sponsoring the media room! Chris Frew Cat Thoreson Bryan Kennedy Annabel Baldy Owen Buzy

Happy Holidays!! enjoy :)

🚨 For Our Followers in Philly: Here’s a Great Event You Won’t Want to Miss! 🚨 CIC (Cambridge Innovation Center) and uCity Square are teaming up to host their first-ever jointly hosted CIC Open House at 3675 Market Street—a cutting-edge life sciences hub in the heart of University City. The first open house will take place on January 22nd, 2025. 📅 Event Highlights: >> Tours: 8:30 AM | 9:30 AM | 10:30 AM >> Explore: Labs, tenant spaces, poster sessions >> Connect: Meet local scientists, students, and business leaders >> Engage: Hands-on activities hosted by the CIC team

🎤Our first of many new interviews to come from our time at the CIC (Cambridge Innovation Center) Philadelphia’s 3rd Vendor Showcase!🎤 Building on the momentum from officially launching our BioBuzz - Greater Philadelphia community, we were thrilled to partner with CIC (Cambridge Innovation Center), uCity Square, and University City Science Center for their 3rd Vendor Showcase. Special thanks to Persephoni BioPartners for sponsoring the media room! The energy and excitement were undeniable. We kick off our series with Michelle Ottey, PhD from CIC, who spoke with BioBuzz about CIC's 25-year journey of supporting startups and driving innovation globally. She emphasized the significance of CIC's Philadelphia location as a key hub for the life sciences community, nestled in University City near University of Pennsylvania and Drexel University. Michelle also highlighted CIC’s flexible, fully managed lab and office spaces, allowing companies to stay focused on their core missions. This year’s growing Vendor Showcase continues to spotlight innovative life sciences companies and services while strengthening connections across the local ecosystem. Check out the full interview below! ⚡ If you're interested in hosting a Media Room at one of your events, please reach out to us at media@biobuzz.io Chris Frew Cat Thoreson Bryan Kennedy Annabel Baldy Owen Buzy

In our next “What’s the Buzz?!,” we are thrilled to welcome John Newby, CEO of Virginia Bio. John will share the key initiatives his team is leading to establish Virginia as a vital force in the life sciences industry, including transformative advancements in the Petersburg and Richmond areas, and efforts to strengthen Virginia’s role as a key player in the BioCapital Region through strategic partnerships. 𝐀𝐛𝐨𝐮𝐭 𝐉𝐨𝐡𝐧 𝐍𝐞𝐰𝐛𝐲 John Newby is the CEO at Virginia Bio, the statewide non-profit trade association for the life science industry. Nearly 300 entities spanning biopharmaceuticals, medical device, med tech, diagnostics, digital health, bioinformatics, agriculture and industrial bio and related fields are based in Virginia, mainly clustered around research universities and medical institutions. Virginia Bio is the sole state affiliate and works closely with key national industry organizations Biotechnology Innovation Organization (BIO), AdvaMed, Medical Device Manufacturers Association (MDMA), @Pharmaceutical Research and Manufacturers Association (PhRMA) and We Work For Health. Newby was formerly the Commissioner of the Virginia Department of Veterans Services (VDVS), where he led an 850-member Agency located across 50 Virginia locations, delivering employment, education, benefits, behavioral health and long term health care services to Virginia’s Reservists, Guardsmen, transitioning service members and 725,000 veterans. Prior to leading VDVS Newby practiced corporate, intellectual property and Hatch-Waxman biopharmaceutical law at international law firms in Richmond and Washington DC, and at a multinational company. Newby previously commanded an Air Force special operations unit supporting the U.S. Army’s 3rd and 7th Special Forces Groups (Airborne), and served in Iraq as an aviator aboard the Boeing B-1B Lancer strategic bomber. Newby received a B.S. from the United States Air Force Academy, with Military Distinction, and his J.D. from the University of Virginia School of Law. Sponsored by CRB.

Start 2025 off right with our first “What’s the Buzz?!” of the year. We’ll sit down with Thomas Luginbill, Executive Director of the Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC). Join us as Thomas shares the vision for transforming PIC MC into a thriving hub of education, business, and innovation, fostering growth and collaboration among academic, corporate, and government partners. 𝐀𝐛𝐨𝐮𝐭 𝐓𝐡𝐨𝐦𝐚𝐬 𝐋𝐮𝐠𝐢𝐧𝐛𝐢𝐥𝐥 Thomas Luginbill is the executive director at Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC). In this role, he leads efforts to expand PIC MC as a hub for education, business, and innovation, fostering collaboration among academic, corporate, and government partners. Luginbill has extensive experience in innovation and community development, including leading the Entrepreneur & Innovation Institute at the College of Southern Maryland, where he revitalized the town of Indian Head and launched the Velocity Center. He also managed the Techport Incubator at the University of Maryland College Park, supporting start-ups and workforce development. Luginbill has a master’s from the University of Maryland and received his bachelor’s from the University of Delaware. Sponsored by CRB.

This is Persephoni BioPartners winning approach to startup success 🚀 and why they go all in with their portfolio companies. That's why when they bring companies or ideas to key decision makers at #investment funds and big pharma, they take notice. Watch the full interview with Hilary Schultz and William Heath right here -> https://lnkd.in/euHnpunD #venturestudio #startup #biotechinvestment

What’s the Buzz?! Accelerating Innovation: The Persephoni Way Sponsored by Kymanox this episode features Pennsylvania's newest life science #VentureStudio + investor - Persephoni BioPartners. Featuring special guests Hilary Schultz, MS, CEO of Persephoni BioPartners, and William Heath, Ph.D., CSO, together they will share how Persephoni’s innovative model guides early-stage biotech companies from conception to clinical stages, rivaling the internal R&D processes of large pharmaceutical companies. Discover how their collaborative approach accelerates growth, blending the agility of early academic spinouts with the robust development frameworks of established pharma. About Hilary Schulz: Hilary Schulz, MS, is an internationally recognized serial entrepreneur with a dynamic background spanning private equity, venture capital, biotechnology, and academic-to-industry company formation. As CEO of Persephoni BioPartners, Hilary leverages her deep expertise to foster early-stage biotech innovation. A Harvard-trained molecular biologist with a Master’s in Biomedicine and Business from Drexel University, Hilary has driven transformative growth in life sciences. She was instrumental in scaling Nucleate Bio’s accelerator program, supporting expansion to 18 global regions and contributing to ventures that collectively raised over $170 million. At Persephoni, Hilary has built essential partnerships and leadership teams, aiming to secure $100 million in venture funding to fuel Philadelphia’s biotech ecosystem. Recognized among the Top 100 entrepreneurs and innovators of 2023, Hilary continues to champion impactful biotech advancements. About William (Bill) Heath, Ph.D.: Dr. William Heath brings over 36 years of leadership in pharmaceutical discovery, development, and commercialization across multiple therapeutic areas. As CSO at Persephoni BioPartners, Bill applies his extensive experience to advance early-stage biotech companies through strategic development frameworks. A Ph.D. graduate from The Rockefeller University with postdoctoral studies at Harvard Medical School, Bill’s illustrious career includes pivotal roles at Eli Lilly, where he spearheaded biotherapeutics initiatives and led global R&D efforts. As Group Vice President at Lilly Research Laboratories, he managed multi-site teams, driving innovation and the launch of several successful medicines. Bill’s commitment to scientific excellence, diversity, and mentorship has made him a respected figure in the industry, passionate about guiding the next generation of biotech leaders. Register now!